Skip to main content
. Author manuscript; available in PMC: 2013 Aug 22.
Published in final edited form as: Science. 2013 Mar 29;339(6127):1546–1558. doi: 10.1126/science.1235122

Fig. 1. Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies.

Fig. 1

(A) The genomes of a diverse group of adult (right) and pediatric (left) cancers have been analyzed. Numbers in parentheses indicate the median number of nonsynonymous mutations per tumor. (B) The median number of nonsynonymous mutations per tumor in a variety of tumor types. Horizontal bars indicate the 25 and 75% quartiles. MSI, microsatellite instability; SCLC, small cell lung cancers; NSCLC, non–small cell lung cancers; ESCC, esophageal squamous cell carcinomas; MSS, microsatellite stable; EAC, esophageal adenocarcinomas. The published data on which this figure is based are provided in table S1C.